Store
IVD Market Brief Update, 2021
Publication Date: October 29, 2021
Tags: Coagulation, COVID-19, Diagnostic Instruments, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, Molecular Diagnostics, Oncology and Cancer, Patient Monitoring and Telehealth, Point-of-Care (POC) Testing
Pages: 35
SKU: 21-037
What is the Size of the IVD Market in 2021?
What Major Trends are Affecting the Market in 2021?
Diagnostic test products have never been more crucial. This report, IVD Market Brief Update, 2021, is an updated analysis of the in vitro diagnostics (IVD) market from Kalorama Information, reflecting the latest data as of Q4 2021. It includes market sizing for several key categories within the IVD sector.
The demand for diagnostic testing and the adoption of current and new technologies continue to drive growth across most areas of the IVD market. New products, shifts in global health spending, regulatory changes in major markets, and disease trends contribute to the evolving market landscape. Several growing segments have captured industry attention, including next-generation sequencing (NGS), cancer testing, and companion diagnostics technologies. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also segments of significant market interest and are expected to play a major role in the future of IVD. The IVD market remains dynamic, consistently showcasing innovations.
Kalorama Information provides a comprehensive overview of the IVD market and its rapidly changing landscape. While COVID-19 has positively impacted the IVD diagnostics market, forecasting has become challenging due to the pandemic’s uncertain trajectory. However, Kalorama Information stands out for its in-depth market insights, thanks to the extensive experience of its authors and the company’s commitment to delivering the most accurate data available.
Explore this detailed report to understand the size, trends, and future directions of the IVD market in 2021, and stay ahead in this rapidly evolving industry.
Table: Global In Vitro Diagnostic Sales, by Product Market, 2021 ($ million)
| Product | 2021 | %Mkt |
| Chemistry | $XX Million | XX% |
| Immunoassays | $XX Million | XX% |
| Infectious disease | $XX Million | XX% |
| Other immunos | $XX Million | XX% |
| Blood bank screening | $XX Million | XX% |
| Drugs of Abuse | $XX Million | XX% |
| Diabetes HbA1c, lab | $XX Million | XX% |
| Hematology – Core Lab | $XX Million | XX% |
| Microbiology (ID/AST) | $XX Million | XX% |
| Microbiology (molecular) | $XX Million | XX% |
| Microbiology – Mass Spectrometry | $XX Million | XX% |
| Coagulation (PT/INR) | $XX Million | XX% |
| Coagulation, molecular | $XX Million | XX% |
| D-dimer | $XX Million | XX% |
| Histology/cytology | $XX Million | XX% |
| HPV, molecular | $XX Million | XX% |
| Nucleic acid assays/genetic tests | $XX Million | XX% |
| Blood grouping/typing | $XX Million | XX% |
| Blood bank molecular – NAT Screens | $XX Million | XX% |
| Circulating tumor cells | $XX Million | XX% |
| POC, OTC diabetes | $XX Million | XX% |
| POC, OTC other | $XX Million | XX% |
| POC, professional/hospital | $XX Million | XX% |
| Mass Spectrometry | $XX Million | XX% |
| Other (transplant testing, other) | $XX Million | XX% |
| IVD Market Total | $XX Million | XX% |
Source: Kalorama Information
Table of Contents
Chapter 1: Worldwide IVD Market – Q4 2021 Update
- IVD Market Demand and Growth
- COVID-19 Diagnostic Markets
- Effect of COVID-19 on Market Segments
Chapter Two: Product Trends and New Developments
- Selected New Core IVD Product Launches and Developments
- Clinical Chemistry
- Hematology
- Molecular
- Companion Diagnostics
- Microbiology
- POC
- Mass Spectrometry
- COVID-19 Developments – September 2021 and Beyond
- Antigen
- Serology
- Molecular
Chapter Three: Selected IVD Market Participant Developments
- Selected Competitive Leader Updates
- Q3 M&A Activity
- Abbott Laboratories
- Company Update
- Agilent
- Company Update
- Becton Dickinson and Co
- Company Update
- bioMérieux SA
- Company Update
- Danaher
- Company Update
- Hologic, Inc.
- Company Update
- Illumina
- Company Update
- Ortho Clinical Diagnostics
- Company Update
- Perkin Elmer
- Company Update
- Quidel Corporation
- Company Update
- Roche Diagnostic
- Company Update
- Siemens Healthineers
- Company Update
- Thermo Fisher Scientific
- Company Update
Chapter Four: New Opportunities
- Telehealth and Remote Patient Monitoring Update
- Multiplex and Syndromic Testing
- Personalized Medicine
- Point-of-Care
Related products
Hematology and Coagulation Markets, 2023
April 5, 2023
Discover the lucrative $10 billion-dollar market for hematology and coagulation in vitro diagnostic (IVD) testing with Kalorama’s comprehensive report, Hematology and Coagulation Markets, 2023. This analysis delves into the dynamic growth factors driving this market, including new technologies, the aging population, and the increasing demand for decentralized testing.
Key Insights Provided:
- Market sizing…
Price range: $3,000.00 through $4,500.00
Clinical Laboratory Services Market, 8th Edition
May 18, 2023
Laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more. Kalorama Information’s Clinical Laboratory Services Market, 8th Edition is your comprehensive resource for insights…
Price range: $4,000.00 through $6,000.00
Cell Therapy and Gene Therapy Disease Markets, 2023-2029
April 30, 2024
Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…
Price range: $5,000.00 through $7,875.00
